DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 1Taro Pharmaceutical Industries
03 8Strides Pharma Science
04 2Granules India Limited
05 6ANI Pharmaceuticals Inc
06 1Acme Lifetech
07 5Actavis Inc
08 2Ajanta Pharma Limited
09 3Amneal Pharmaceuticals
10 1Amnos Lifesciences
11 2Apofri AB
12 5Apotex Inc
13 2Appco Pharmaceutical Corp
14 5Aurobindo Pharma Limited
15 2Avet Pharmaceuticals
16 1BEDFORD LABS
17 2Boehringer Ingelheim GmbH
18 4Chattem Chemicals, Inc
19 1Contract Pharmacal Corporation
20 2ENDO OPERATIONS
21 1Epic Pharma. LLC.
22 13GSK
23 2Glenmark Pharmaceuticals
24 2Glumex Pharmaceuticals Mfg. Pvt. Ltd
25 1Grupo Columbia
26 2Hikma Pharmaceuticals
27 2Ind Swift Laboratories Limited
28 2Kolmar Korea Co., Ltd.
29 1Kusum Healthcare Pvt Ltd
30 2Lannett Company, Inc.
31 1Lifespan Biotech
32 2MARCAN PHARMACEUTICALS INC
33 2MINT PHARMACEUTICALS INC
34 2Meda OTC AB
35 2Myungmoon Pharm. Co., LTD.
36 5NORVIUM BIOSCIENCE
37 1Nobel Ilac Sanayii Ve Ticaret A.S.
38 4Nostrum Laboratories
39 2Novitium Pharma LLC
40 2ORIFARM GROUP AS
41 3PAI Pharmaceutical Associates
42 1PHARM ASSOC
43 3Perrigo Company plc
44 4Pharmascience Inc.
45 4RANBAXY LABORATORIES LIMITED
46 9Sandoz B2B
47 3Sun Pharmaceutical Industries Limited
48 2THINQ Pharma-CRO PVT Ltd
49 2Teva Pharmaceutical Industries
50 1Theon Pharmaceuticals
51 1Tolmar
52 1Torrent Pharmaceuticals Limited
53 3Umedica Laboratories
54 2VKT Pharma
55 6Viatris
56 2Vista Pharmaceuticals
57 9Wockhardt
58 4XYZ Pharma
59 1Zydus Pharmaceuticals
01 1Ampoule
02 18CAPSULE;ORAL
03 7EFFERVESCENT TABLET
04 9FILM COATED PILL
05 2Film Coated Tablet
06 1GRANULE, EFFERVESCENT;ORAL
07 8INJECTABLE;INJECTION
08 4INJECTION
09 2Injection
10 1ORAL SOLUTION
11 1SOLUTION FOR INJECTION
12 17SYRUP;ORAL
13 16TABLET
14 3TABLET, EFFERVESCENT;ORAL
15 74TABLET;ORAL
16 5Tablet
01 105DISCN
02 10Generic
03 4OTC
04 6Prescription
05 14RX
06 30Blank
01 1ACID REDUCER
02 1ACTITAC-300
03 1Aciran 150
04 1Aciran 300
05 1Almiso Tablet
06 1Curodin
07 1Inside
08 1Inside Brus
09 2MAR-RANITIDINE
10 1MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION
11 2MINT-RANITIDINE
12 1PMS-RANITIDINE 150 MG
13 1PMS-RANITIDINE 300 MG
14 1Peptimax
15 106RANITIDINE HYDROCHLORIDE
16 1RINIT
17 1Ramisin
18 1Rani-Q
19 2Ranitidine Apofri
20 1Ranitidine HCl Injection
21 2Ranitidine Mylan
22 4Ranitidine Sandoz
23 1Ranobel
24 2Stomacid
25 3UMETAC
26 2ZANTAC
27 6ZANTAC 150
28 1ZANTAC 25
29 2ZANTAC 300
30 2ZANTAC 75
31 2ZANTAC IN PLASTIC CONTAINER
32 4Zantac
33 1Zantac Noise
34 2ranitidine Actavis
35 7Blank
01 8Canada
02 14India
03 4South Korea
04 20Sweden
05 1Turkey
06 121USA
07 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2005-07-27
Application Number : 76705
Regulatory Info : RX
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2011-06-28
Application Number : 200536
Regulatory Info : DISCN
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2018-08-20
Application Number : 210243
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 300MG BASE
Packaging :
Approval Date : 2005-07-27
Application Number : 76705
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANITIDINE HYDROCHLORIDE
Dosage Form : SYRUP;ORAL
Dosage Strength : EQ 15MG BASE/ML
Packaging :
Approval Date : 2011-06-13
Application Number : 77476
Regulatory Info : DISCN
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2012-02-29
Application Number : 201745
Regulatory Info : DISCN
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2016-08-22
Application Number : 205512
Regulatory Info : DISCN
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 300MG BASE
Packaging :
Approval Date : 2016-08-22
Application Number : 205512
Regulatory Info : DISCN
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2018-03-05
Application Number : 209160
Regulatory Info : DISCN
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2018-02-22
Application Number : 209161
Regulatory Info : DISCN
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2018-08-01
Application Number : 210010
Regulatory Info : DISCN
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 300MG BASE
Packaging :
Approval Date : 2018-08-01
Application Number : 210010
Regulatory Info : DISCN
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2018-08-20
Application Number : 210243
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZANTAC 150
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1983-06-09
Application Number : 18703
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZANTAC 300
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1985-12-09
Application Number : 18703
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZANTAC
Dosage Form : SYRUP;ORAL
Dosage Strength : EQ 15MG BASE/ML
Packaging :
Approval Date : 1988-12-30
Application Number : 19675
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZANTAC 150
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-03-08
Application Number : 20095
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZANTAC
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 25MG BASE/ML
Packaging :
Approval Date : 1984-10-19
Application Number : 19090
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZANTAC IN PLASTIC CONTAINER
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 50MG BASE/100ML
Packaging :
Approval Date : 1986-12-17
Application Number : 19593
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZANTAC IN PLASTIC CONTAINER
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 1991-09-27
Application Number : 19593
Regulatory Info : DISCN
Registration Country : USA
LOOKING FOR A SUPPLIER?
